pubmed-article:12133113 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12133113 | lifeskim:mentions | umls-concept:C0037369 | lld:lifeskim |
pubmed-article:12133113 | lifeskim:mentions | umls-concept:C0337664 | lld:lifeskim |
pubmed-article:12133113 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:12133113 | lifeskim:mentions | umls-concept:C0036341 | lld:lifeskim |
pubmed-article:12133113 | lifeskim:mentions | umls-concept:C0814225 | lld:lifeskim |
pubmed-article:12133113 | lifeskim:mentions | umls-concept:C0449445 | lld:lifeskim |
pubmed-article:12133113 | lifeskim:mentions | umls-concept:C0443220 | lld:lifeskim |
pubmed-article:12133113 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:12133113 | pubmed:dateCreated | 2002-7-22 | lld:pubmed |
pubmed-article:12133113 | pubmed:abstractText | We evaluated literature that addresses the notion that flexible smoking treatment approaches are warranted for smokers with a diagnosis of schizophrenia. Understanding the biological and psychological mechanisms that increase the likelihood of smoking and decrease the motivation to quit for these individuals is addressed within the framework of a neurobiological model. We provide a brief overview of the limited smoking cessation treatment literature for patients with schizophrenia and compare abstinence-focused versus reduction-focused treatment modalities. The potential utility of the reduction-focused approach to tobacco treatment for these smokers is evaluated. Suggestions for future research to address the utility and efficacy of reduction-focused interventions for smokers with schizophrenia are put forth. We conclude with a consideration of the implications for the current understanding of smoking treatment among patients with co-morbid psychiatric diagnoses. | lld:pubmed |
pubmed-article:12133113 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12133113 | pubmed:language | eng | lld:pubmed |
pubmed-article:12133113 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12133113 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12133113 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12133113 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12133113 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12133113 | pubmed:month | Jul | lld:pubmed |
pubmed-article:12133113 | pubmed:issn | 0965-2140 | lld:pubmed |
pubmed-article:12133113 | pubmed:author | pubmed-author:McChargueDenn... | lld:pubmed |
pubmed-article:12133113 | pubmed:author | pubmed-author:GulliverSuzy... | lld:pubmed |
pubmed-article:12133113 | pubmed:author | pubmed-author:HitsmanBrianB | lld:pubmed |
pubmed-article:12133113 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12133113 | pubmed:volume | 97 | lld:pubmed |
pubmed-article:12133113 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12133113 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12133113 | pubmed:pagination | 785-93; discussion 795-800 | lld:pubmed |
pubmed-article:12133113 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:12133113 | pubmed:meshHeading | pubmed-meshheading:12133113... | lld:pubmed |
pubmed-article:12133113 | pubmed:meshHeading | pubmed-meshheading:12133113... | lld:pubmed |
pubmed-article:12133113 | pubmed:meshHeading | pubmed-meshheading:12133113... | lld:pubmed |
pubmed-article:12133113 | pubmed:meshHeading | pubmed-meshheading:12133113... | lld:pubmed |
pubmed-article:12133113 | pubmed:meshHeading | pubmed-meshheading:12133113... | lld:pubmed |
pubmed-article:12133113 | pubmed:meshHeading | pubmed-meshheading:12133113... | lld:pubmed |
pubmed-article:12133113 | pubmed:meshHeading | pubmed-meshheading:12133113... | lld:pubmed |
pubmed-article:12133113 | pubmed:meshHeading | pubmed-meshheading:12133113... | lld:pubmed |
pubmed-article:12133113 | pubmed:meshHeading | pubmed-meshheading:12133113... | lld:pubmed |
pubmed-article:12133113 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:12133113 | pubmed:articleTitle | Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment? | lld:pubmed |
pubmed-article:12133113 | pubmed:affiliation | Edward Hines Jr VA Hospital, Hines, IL 60607-7137, USA. | lld:pubmed |
pubmed-article:12133113 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12133113 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:12133113 | pubmed:publicationType | Review | lld:pubmed |
pubmed-article:12133113 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12133113 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12133113 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12133113 | lld:pubmed |